亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Plasma Volume Measurement Using Tagged Macromolecules

總結
Lead Inventors: Bashir ZikriaProblem or Unmet Need:In sick patients inflammatory signals result in "capillary leak" allowing albumin to leak out of the capillaries into the interstitial space. Historically plasma volume has been measured with iodinated serum albumin and red blood cell (RBC) volume by radioactive chromium labeled autologous RBC. These two measurements are compared to calculate total blood volume. The accuracy of this technique is good in healthy individuals, but in sick individuals it is not very accurate due to loss of labeled albumin. The blood volume determination remains accurate because even in leaky capillaries RBCs, due to their size and shape, rarely leak out.Very large macromolecules such as FITC dextran are functionally similar to tagged RBCs. Because of their large size they do not leak out of the intravascular space even in subjects with capillary leak. They are stable over a period of several days and are easily quantified without the use of radioactivity.This invention is a method of determining the volume of plasma in a patient by introducing into the circulation a predetermined amount of biodegradable, nontoxic macromolecules. These molecules are sufficiently larger than endothelial junctions as to be incapable of leaking out of the patient's capillaries. Each macromolecule is labeled with a detectable marker such that, after a period of time sufficient for distribution of the macromolecules throughout the patient's circulatory system, a plasma sample can be collected and the concentration of the macromolecule can be rapidly determined. The known quantity of macromolecule introduced will allow total plasma volume to be calculated from the concentration. This invention has been tested using FITC dextran 2000k in both normal rats and rats in hemorrhagic shock and has been shown to be accurate in both cases.
技術優勢
Accurate in healthy and sick patients. Can be carried out without the use of radioactivity. Quick to administer and simple to detect with a relatively inexpensive flourometerOpportunities Development of labeled macromolecules Development of diagnostic package (injectable macromolecule solution and detection equipment)
技術應用
Assay for determination of blood plasma volume
詳細技術說明
This invention is a method of determining the volume of plasma in a patient by introducing into the circulation a predetermined amount of biodegradable, nontoxic macromolecules. These molecules are sufficiently larger than endothelial junctions as t...
*Abstract
None
*Inquiry
Sara Gusik Columbia Technology Ventures Tel: (212) 854-8444 Email: TechTransfer@columbia.edu
*IR
473
*Principal Investigation
*Web Links
EP: AU4410196USPTO: US 5,685,302USPTO_2: US 5,704,358
國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備